Related Experiment Video
Updated: Jan 12, 2026
Biochemical and Structural Characterization of the Carbohydrate Transport Substrate-binding-protein SP0092
Published on: October 2, 2017
Analysis of lipoprotein SPD_0792 from Streptococcus pneumoniae as a potential vaccine candidate
Shabnam Shabnam1, Kaur Kaur1, Devinder Sehgal1
1Molecular Immunology Laboratory, National Institute of Immunology, Aruna Asaf Ali Marg, New Delhi, India.
Insights
A novel protein, SPD_0792, shows promise as a broadly protective, serotype-independent vaccine antigen against Streptococcus pneumoniae. This research supports its development for next-generation pneumococcal vaccines.
Area of Science:
- * Microbiology and Vaccinology
- * Protein Engineering and Structural Biology
Background:
- * Streptococcus pneumoniae poses a significant global health burden, particularly for vulnerable populations.
- * Current polysaccharide vaccines are limited by cost and serotype replacement, driving the need for new approaches.
- * Protein-based vaccines offer potential for broader and more cost-effective protection.
Purpose of the Study:
- * To evaluate SPD_0792, a conserved surface lipoprotein, as a potential vaccine candidate against Streptococcus pneumoniae.
- * To investigate the immunogenic properties and structural characteristics of SPD_0792.
Main Methods:
- * Sequence analysis for conservation and surface localization prediction.
- * Identification of B-cell and T-cell epitopes.
- * Structural modeling using GalaxyRefine and experimental cloning, expression, and purification of SPD_0792.
Main Results:
- * SPD_0792 exhibits high sequence conservation and predicted surface localization.
- * Multiple B-cell and helper T-cell epitopes were identified within SPD_0792.
- * Structural modeling indicated a stable protein fold, and the protein was successfully cloned and expressed.
Conclusions:
- * SPD_0792 demonstrates significant potential as a novel, serotype-independent antigen.
- * These findings support the development of SPD_0792 for next-generation pneumococcal vaccines.
- * Further research is warranted to fully characterize SPD_0792's efficacy in vaccine formulations.
Abstract:
Streptococcus pneumoniae remains a major global health threat, especially in young children and the elderly. Although vaccines are available, polysaccharide-based (serotype-specific) formulations are limited by high costs and rising serotype replacement. As a result, there is growing interest in developing a broadly protective, protein-based vaccine. Therefore, it is of interest to investigate SPD_0792, a putative lipoprotein, as a potential vaccine candidate. Sequence analyses revealed high conservation and surface localization. The presence of multiple B-cell and helper T-cell epitopes in SDP_0792 were identified. Structural modelling and refinement using the GalaxyRefine server confirmed a stable fold comprising of 38.9% α-helices. SPD_0792 was successfully cloned, expressed and partially purified. These findings support the potential of SPD_0792 as a novel, serotype-independent antigen for next-generation pneumococcal vaccines.
More Related Videos
08:47Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens
Published on: April 5, 2019
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Related Concept Videos
02:50Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
01:19Formation of Lipopolysaccharides